YGX-2

N/A

Report date: 2024/04/09 18:02:37

Base Information

Drug NameYGX-2
Drug Alias NameYGX2YGX-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesYoungene Therapeutics Inc Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYoungene Therapeutics Inc Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A